The Promise of 21st Century Science: Goals for the Global Alliance for Vaccines and Immunization
Sir Gustav Nossal
University of Melbourne

• The World Bank Perspective
  Amie E. Batson, M.B.A.
  The World Bank

• The Industry Perspective
  Michel De Wilde, Ph.D. Aventis Pasteur

• A single additional dose of hepatitis B vaccine is enough for children who are not protected after 3 doses
  Presenting Author: Bernard Duval, M.D.
  CHUL Research Centre

• Would a single large dose of hepatitis B vaccine be sufficient for high risk young adults?
  Presenting Author: Simon R. Dobson, M.D.
  B.C. Children's Hospital

• An Inactivated Influenza Vaccine Produced from an MDCK-derived Cell Line is Safe and Immunogenic in Healthy Adults, Children and the Elderly
  Presenting Author: Scott A. Halperin, M.D.
  Dalhousie University

• Effectiveness of Inactivated Influenza Vaccination of Children Attending Day Care in Reducing Influenza-like Illnesses and Related Morbidity
  Presenting Author: Eugene S. Hurwitz, M.D.
  Centers for Disease Control and Prevention

• Immunity against tetanus and diphtheria in hemodialysis patients five years after vaccination
  Presenting Author: Sabine Krüger, M.D.
  Institute of Immunology and Transfusion Medicine

• Current Status of the RIVM Men B vaccine development
  Presenting Author: Loek A.J.W. van Alphen, Ph.D.
  RIVM

• Oral vaccination of mice with virus-like particles of oncogenic human papillomaviruses
  Presenting Author: Robert C. Rose, Ph.D.
  University of Rochester Medical Center

• Immunization of mice, guinea pigs and nonhuman primates with alphavirus replicons expressing the herpes simplex virus type 2 glycoprotein D
  Presenting Author: Deborah A. Long, Ph.D.
  Wyeth-Lederle Vaccines

• A Live Apathogenic Nonlatent HSV-1 Recombinant R15 Protects Mice Against Challenge with a Pathogenic Virus
  Presenting Author: Yechiel Becker, Ph.D.
  Hebrew University of Jerusalem Faculty of Medicine

• Functional Mapping of Protective Domains and Epitopes in the Rotavirus VP6 Protein
  Presenting Author: Anthony H.-C. Choi, Ph.D.
  Children's Hospital Medical Center

• Nasal Vaccines Induced Higher Levels of Systemic Antibodies, But Equal levels of Mucosal Antibodies, When Given to Anaesthetized Rather Than Fully Awake Mice
  Presenting Author: Libuse Janakova, M.Sc.
  National Institute of Public Health

• A Subunit Proteosome Influenza Vaccine Induces Mucosal IgA, Serum HAI and Protection against Challenge following Nasal Immunization
  Presenting Author: David Burt, Ph.D.
  Intellivax International Inc.

• Status Report on the Global Initiative to Eradicate Polio
  Harry F. Hull, M.D.
  World Health Organization

• Is A Global Initiative to Eradicate Measles Epidemiologically and Logistically Feasible?
  Ciro de Quadros, M.D.
  Pan American Health Organization

• Efforts to Control Invasive Disease Caused by Haemophilus influenzae type b: A Global View
  Joel I. Ward, M.D.
  Harbor-UCLA Medical Center

Symposium 3: Immunologic Responses at the Extremes of Life

• Animal Models for Aging and Vaccine Responses
  Garnett H. Kelsoe, D.Sc.
  Duke University Medical Center

• Immunological Basis of Vaccine Responses in the Elderly
  Beatrix Grubeck-Loebenstein, M.D.
  Austrian Academy of Sciences

• Challenge of Immunization in Early Infancy
  Claire-Anne Siegrist, M.D., P.D.
  Centre MÈdical Universitaire de GenËve

• Quality of Immune Responses to PS in Infancy
  David Goldblatt, M.B.Ch.B., Ph.D.
  Institute of Child Health

• Use of In Vivo Induced Antigen Technology (IVIAT) for Rationale Vaccine Design
  Presenting Author: Jeffrey D. Hillman, D.M.D., Ph.D.
  University of Florida

• Protective Intranasal Diphtheria Vaccination with rCtB
  Presenting Author: Harold H. Handley, Jr., Ph.D.
  Maxim Pharmaceuticals

• Protection Induced by Recombinant BCG-DPT Vaccines
  Presenting Author: Luciana C.C. Leite, Ph.D.
  Instituto Butantan

• Comparison of bivalent meningococcal vaccines: conjugated polysaccharide C-outer membrane vesicle and conjugate polysaccharide C- tetanus toxoid plus outer membrane vesicle
  Presenting Author: Isaias Raw, Ph.D.
  Instituto Butantan

• Optimization and evaluation of Nabi-StaphVAX®, a Staphylococcus aureus bivalent glycoconjugate vaccine, in hemodialysis patients
  Presenting Author: Ali Fattom, Ph.D.
  Nabi

• First Clinical Investigation of New Lipopolysacchairdes: Phase I-II Clinical Trials of Shigellae sonnei LPS Vaccines
  Presenting Author: Petr G. Aparin
  National Research Center--Institute of Immunology

• Possible Role of Cell-mediated Immunity in Injection Site Reactions to a Second Booster Dose of an Acellular Pertussis-based Combination Vaccine
  Presenting Author: David W. Scheifele, M.D.
  BC Children's Hospital

• Safety, tolerability, and immunogenicity of varying doses of influenza vaccine administered by jet injector (JI) vs. needle and syringe (N&S)
  Presenting Author: Lisa A. Jackson, M.D.
  Center for Health Studies/Group Health

• Pertussis Vaccination and Risk of Asthma in Childhood
  Presenting Author: Piotr Kramarz, M.D.
  Centers for Disease Control and Prevention

• Demographic and Clinical Features of Patients Developing Myositis Following Immunizations
  Presenting Author: Ejaz A. Shamim, M.D.
  CBER/FDA

• Evaluation of transmission risks of avian leukosis virus and endogenous avian retrovirus to recipient of chick-cell-derived reverse transcriptase-positive MMR vaccine
  Presenting Author: Althaf I. Hussain, Ph.D.
  Centers for Disease Control and Prevention

• Should we worry that some nurses no longer fully support immunization?
  Presenting Author: Bernard Duval, M.D.
  CHUL Research Centre

• CpG ODN is safe and highly effective in humans as adjuvant to HBV vaccine: Preliminary results of Phase I trial with CpG ODN 7909
  Presenting Author: Heather L. Davis, Ph.D.
  Loeb Research Institute, University of Ottawa

• Using C3d to Increase the Immunogenicity of HIV-1 Envelope and Influenza Hemagglutinin in Mice
  Presenting Author: Ted M. Ross, Ph.D.
  Emory University

• Evaluation of Carbohydrate-PADRE Peptide Conjugate Vaccine Technology
  Presenting Author: Mark J. Newman, Ph.D.
  Epimmune, Inc.

• Novel Synthetic LPS Receptor Agonists as Vaccine Adjuvants
  Presenting Author: Sally T. Ishizaka, Ph.D.
  Eisai Research Institute

• SP1017: a novel class of gene delivery system to improve DNA vaccines
  Presenting Author: Pierre M. Lemieux, Ph.D.
  Supratek Pharma Inc.

• Immunization with pp89 ie1-CTL epitope and with p278m heat-shock-protein 60 peptide may confer protection against murine cytomegalovirus infection
  Presenting Author: Ory Rouvio, M.Sc.
  Ben-Gurion University of the Negev

• International Strategy for the Evaluation of AIDSVAX HIV VaccineãPreliminary Results from North America, Europe and Thailand
  Presenting Author: John G. Curd, M.D.
  VaxGen, Inc.

• Phase I/II Safety and Immunogenicity Trial of Bivalent B/E rgp120 HIV Vaccine (AIDSVAX^tm B/E) in Bangkok, ThailandãInitial Report

  Presenting Author: Punnee Pitisuttithum, M.D.
  Mahidol University

• A novel genetic immunization induces vigorous Th-1 restricted, HIV-specific immune responses
  Presenting Author: Julianna Lisziewicz, Ph.D.
  Research Institute for Genetic and Human Therapy

• Enhanced Binding and Neutralization of Primary Isolate Virions by Combinations of Human Monoclonal Antibodies
  Presenting Author: Lisa A. Cavacini, Ph.D.
  Beth Israel Deaconess Medical Center

• Neutralizing Antibody (NAb) Responses to ALVAC-HIV (vCP205) + oligomeric gp160 MN/LAI-2 Prime Boost in HIV-Seronegative Volunteers
  Presenting Author: Jerome H. Kim, M.D.
  Henry M. Jackson Foundation

• Full genome sequencing of HIV-1 reveals new complexity in the pandemic
  Presenting Author: Francine E. McCutchan, Ph.D.
  Henry M. Jackson Foundation

• Group A Streptococcus Vaccines
  Fran A. Rubin, Ph.D.
  Respiratory Division
  National Institute of Allergy and Infectious Diseases

• Respiratory Syncytial Virus Vaccines
  Brian Murphy, M.D.
  National Institute of Allergy and Infectious Diseases

• Pneumococcal Conjugate and Non conjugate Vaccines
  Robert F. Breiman, M.D.
  Scientific Program Committee

• Influenza Vaccines
  Kristin L. Nichol, M.D.
  University of Minnesota School of Medicine
  Minneapolis VA Medical Center

Symposium 5: Vaccines for Sexually Transmitted Infections

• Mucosal Immunization for Sexually Transmitted Infections
  Jerry R. McGee, Ph.D.
  University of Alabama at Birmingham

• Vaccines for Genital Herpesvirus Infections
  Lawrence Corey, M.D.
  University of Washington
  Fred Hutchinson Cancer Research Center

• Current Status of Chlamydia Vaccines
  Richard S. Stephens, Ph.D.
  University of California, Berkeley

• Human Papillomavirus Vaccines
  John T. Schiller, Ph.D.
  National Cancer Institute

• Innate Immunity Overview
  Peter L. Nara, D.V.M., Ph.D.
  Biological Mimetics, Inc.
  International Society for Vaccines

• Pattern Recognition and Innate Immunity
  R. Alan B. Ezekowitz, D.Phil., M.B.Ch.B.
  Massachusetts General Hospital
  Harvard Medical School

• Immunogenicity of a nicotine conjugate vaccine (NicVAXÅ) and its evaluation for attenuating nicotine dependency in animal models
  Presenting Author: Ali I. Fattom, Ph.D.
  Nabi

• An Anti-Allergy Vaccine Based on IgE-Related Peptide Mimotopes
  Presenting Author: Franz Kricek, Ph.D.
  Novartis Forschungsinstitut

• Infections with Chlamydiae can be effectively eradicated using herd specific autovaccines in cattle populations
  Presenting Author: Olilver J. Nolte, Ph.D.
  University of Heidelberg

• Enhanced immunogenicity of CMV CTL epitope analogues derived from peptide scanning combinatorial libraries
  Presenting Author: Don J. Diamond, Ph.D.
  City of Hope Medical Center

• Evaluation of Immunotherapy in the SIV Infected Rhesus Macaque Model
  Presenting Author: Jean D. Boyer, Ph.D.
  University of Pennsylvania

• Introduction
  Michael Gottlieb, Ph.D.
  National Institute of Allergy and Infectious Diseases

• Bioinformatics and Predictive Algorithms
  Anne S. DeGroot, M.D.
  Brown University
  EpiVax, Inc.

• High Throughput Screening and Pooled Genomic Sequences
  Stephen A. Johnston, Ph.D.
  University of Texas Southwestern Medical Center

• Point-Counterpoint: The Post-Genomic Era of Microbe Biology
  Stephen Hoffman, M.D.
  Naval Medical Research Center

• Point-Counterpoint: A Pragmatic View of Vaccine R&D
  John B. Robbins, M.D.
  National Institute of Child Health and Human Development

• Preservatives: Friends or Foes?
  William M. Egan, Ph.D.
  Food and Drug Administraion

• Is There a Relationship Between Vaccines and Autoimmune Disease?
  Frederick Miller, Ph.D.
  Food and Drug Administration

• New Cell Substrates: Challenges and Promises
  John Petricciani, M.D.
  International Association for Biologicals

• Eradication of multi-resistant Escherichia coli from a patient with urinary tract infection using specific autovaccination therapy
  Presenting Author: Oliver J. Nolte, Ph.D.
  University of Heidelberg

• In vitro and in vivo activity of anti-FimH against clinical and laboratory isolates of uropathogenic E coli
  Presenting Author: C. Gale Auguste, M.S.
  MedImmune, Inc.

• A Novel Strategy for the Screening of New Streptococcus pneumoniae Immunogenic Proteins
  Presenting Author: Sonia TrÈpanier, Ph.D.
  Laval University Medical Center

• Ubiquitous Sip Protein Confers Protection Against GBS Infections
  Presenting Author: France Couture
  Laval University Medical Center, CHUL

• Development of a New Oral Typhoid Vaccine
  Presenting Author: Hong-Jin Kim, Ph.D.
  Chung Ang University

• Murine antibody response to meningococcal B after immunization with experimental outer membrane vesicle (OMV) vaccines and VA-MENGOC-BC
  Presenting Author: Carl E. Frasch, Ph.D.
  CBER/FDA

• Group B meningococcal peptide mimetics
  Presenting Author: Bambos Charalambous, Ph.D.
  Royal Free and University College Medical School

• Vaccine development against bacterial otitis media
  Presenting Author: Jennelle M. Kyd
  University of Canberra

• A randomized, double blind study in young healthy adults comparing cell mediated and humoral immunogenicity of influenza ISCOM vaccines and conventional vaccines
  Presenting Author: Guus F. Rimmelzwaan, Ph.D.
  Erasmus University

• Th1 or Th2 responses to HSV peptide epitopes is determined by incorporation into LEAPS heteroconjugates
  Presenting Author: Hanwen Mao, M.D.
  Northeastern Ohio Universities College of Medicine

• Transgenic Tobacco for Delivery of Poultry Vaccines against Hemorrhagic Enteritis Virus
  Presenting Author: Tian Yuying
  Virginia Tech, College of Veterinary Medicine

• Long-lived responses to vaccinia virus in HIV-1 seronegative volunteers enrolled in phase I/II HIV vaccine trials
  Presenting Author: Josephine H. Cox, Ph.D.
  U.S. Military HIV Research Program

• Receptor-Mediated Transduction of Dendritic Cells with Plasmid DNA Induces HIV-1-specific Primary Immune Responses in vitro
  Presenting Author: Georg S. Varga, Ph.D.
  Research Institute for Genetic and Human Therapy

• Different analyses of T helper response in a seropositive cohort: implication for differential immune response
  Presenting Author: Silvia Ratto-Kim, Ph.D.
  Henry M. Jackson Foundation

• Interactions of Human Dendritic Cells with ALVAC-HIV (vCP205) a Canarypox HIV-1 Vaccine Candidate
  Presenting Author: Mary A. Marovich, M.D., D.T.M.&H.
  U.S. Military HIV Research Program

• HIV-1 Serotypes among Civilian Applicants for US Military Service
  Presenting Author: Philip O. Renzullo
  U.S. Military HIV Research Program

• US Army-Sponsored HIV Vaccine Clinical Development: Results, Current Status and Future Plans
  Presenting Author: Merlin L. Robb, M.D.
  Walter Reed Army Institute of Research

• Injecting drug users in Guangxi Province, China harbor two highly homogenous, geographically separated HIV-1 strains: CRF AE and a novel BC recombinant
  Presenting Author: Sucheep Piyasirisilp, M.D., Ph.D.
  Johns Hopkins School of Public Health

• First identified AE/B inter-subtype recombinant of HIV-1 is found in Thailand
  Presenting Author: Sodsai Tovanabutra, Ph.D.
  Chiang Mai University

• Utilization of Polymerase Chain Reaction Analysis: An Added Dimension to the Safety Profile for VarivaxÆ [Varicella Virus Vaccine live (OKA/MERCK)]
  Presenting Author: Susan A. Galea, M.S.N.
  Merck & Co., Inc.

• The Role of Class II HLA Homozygosity in Measles Vaccine Virus (MVV) Antibody (Ab) Nonresponse
  Presenting Author: Inna G. Ovsyannikova, Ph.D.
  Mayo Clinic and Foundation

• Vaccination Against Hepatitis B of Patients with Chronic Renal Failure and Influence of Simultaneous Immunomodulatory Treatment
  Presenting Author: Eva JÌlkov·, M.D.
  Institute of Public Health

• Th2 Response Follows Immunization with Inactivated Hepatitis A Vaccine
  Presenting Author: Mary S. Hayney, Pharm.D.
  University of Wisconsin School of Pharmacy

• Chronic Stress and IgG Response to Influenza Vaccination in Elderly Caregivers of Dementia Patients
  Presenting Author: Nigel K.M. Cox, M.Sc.
  University of Bristol

• Antigenic Drift in the Influenza A Virus (H3N2) Nucleoprotein and Escape from Recognition by Cytotoxic T Lymphocytes
  Presenting Author: G.F. Rimmelzwaan, Ph.D.
  Erasmus University

• Concomitant Administration of COMVAX^tm with M-M-R® II and Varicella Vaccines
  Presenting Author: Teresa M. Hesley, M.P.H.
  Merck & Co., Inc.

• Prevalence of Immunity to Tetanus in a Rural Wisconsin Population
  Presenting Author: Mary S. Hayney, Pharm.D.
  University of Wisconsin School of Pharmacy

• An Action Plan for Improving the Thermostability of Vaccines for the Developing World
  Presenting Author: Melinda Moree, M.D.
  Program for Appropriate Technology in Health

• An Edible Vaccine to Swine Transmissible Gastroenteritis Virus
  Presenting Author: Joseph M. Jilka, Ph.D.
  ProdiGene

• Vaccines from transgenic plants: Expression of Human Papillomavirus type 11 (HPV-11) L1 capsid protein in tomatoes
  Presenting Author: Heribert Warzecha, Ph.D.
  Boyce Thompson Institute

• Single dose immunisation with controlled release implants
  Presenting Author: Shari A. Lofthouse, Ph.D.
  The University of Melbourne

• Continuous antigen delivery from controlled release implants elicits significant and anamnestic immune responses
  Presenting Author: Shari A. Lofthouse, Ph.D.
  The University of Melbourne

• Epidermal Powder Immunization with Hepatitis B Vaccine
  Presenting Author: Kathleen F. Weis
  PowderJect Vaccines

• The Immunological Memory and Boosting of IgA Antibodies in Secretions Induced by a Non-Replicating Nasal Vaccine Have Different Kinetics From Those of IgG Antibodies in Serum
  Presenting Author: Hilde Bakke, M.Sc.
  National Institute of Public Health

• Intranasal immunization of mice with recombinant protein CbpA truncate reduces nasopharyngeal colonization with Streptococcus pneumoniae
  Presenting Author: Yambasu A. Brewah, M.S.
  MedImmune, Inc.

• Non-Replicating Nasal Vaccines May Be Given Repeatedly in mice Without Causing "Immunological Exhaustion"
  Presenting Author: Inger Lise Haugen
  National Institute of Public Health

• Gag Virus-Like Particles as a Mucosal Vaccine Platform for Staphylococcal Enterotoxin B
  Presenting Author: Steven E. Fong, Ph.D.
  USAMRIID

• Light Biovector^tm Nanoparticles: new antigen delivery systems for vaccine application
  Presenting Author: Didier Betbeder, Ph.D.
  BioVector Therapeutics

• Improved incidence data on Coccidiodes immitis infection are needed to plan future vaccine efficacy trials
  Presenting Author: George W. Rutherford, M.D.
  University of California, San Francisco

• Cost-effectiveness of a potential vaccine against Coccidioides immitis
  Presenting Author: Amber E. Barnato, M.D.
  Stanford School of Medicine

• Hepatitis E Virus (HEV) US-1 Strain is Cross-Neutralized by Immune Sera Against Truncated ORF-2-Encoded Proteins of Different Geographic HEV Strains
  Presenting Author: Jihong Meng, M.D., Ph.D.
  Centers for Disease Control and Prevention

• Protection against lethal anthrax toxin challenge by genetic vaccination with plasmids that encode B. anthracis protective antigen and/or a mutant form of lethal factor
  Presenting Author: Darrell R. Galloway, Ph.D.
  The Ohio State University

• Rapid Identification of Membrane Proteins of Helicobacter pylori by Proteomic for Characterization of Subunit Vaccine Candidates
  Presenting Author: Deb N. Chakravarti, Ph.D., D.Phil.
  Wyeth-Lederle Vaccines

• Primary and secondary responses to a malaria antigen using Immudaptin^tm adjuvants
  Presenting Author: Vivienne F. Cox, Ph.D.
  AdProTech plc

• Storage at -3 degrees C for 24 hours affects the immunogenicity of acellular pertussis vaccine
  Presenting Author: Michael S. Gold, F.R.A.C.P.
  Women's and Children's Hospital

• Immunogenicity and efficacy of DNA vaccines encoding various Leishmania mexicana antigens in mice
  Presenting Author: Eric Dumonteil, Ph.D.
  Universidad Autonoma de Yucatan

• Relationship between cell surface exposure and immunogenicity for epitopes inserted in E. coli outer membranes LamB and OmpA
  Presenting Author: Zengbiao Qi
  University of Oklahoma

• Therapeutic vaccines in the treatment of equine papilloma virus infection
  Presenting Author: Oliver J. Nolte, Ph.D.
  University of Heidelberg

• Clinical and humoral immune responses of cattle vaccinated with an experimental inactivated Anaplasma marginale vaccine in two different adjuvants
  Presenting Author: Sergio D. RodrÌguez, Ph.D.
  CENID-PAVET/INIFAP

• The New Immunomodulatory Adjuvant OM-174 Stimulates Cytotoxic T Lymphocyte Activity Against Peptide and Protein Antigens in Mice
  Presenting Author: Gwyn Davies, D.Phil.
  OM Pharma